🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pedro Gabriel Melo de Barros e Silva

Hospital Samaritano de São Paulo

ORCID: 0000-0003-1940-4470

Also affiliated with Colégio Pedro II

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial”.

Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial

American Heart Journal(2022)10.1016/j.ahj.2022.04.001

N/A

1.1DataRank · unranked

19 citations

Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula, Renata Moll‐Bernardes, Tiago Mendonça dos Santos, Lilian Mazza +10 more

Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial

Circulation(2024)10.1161/circulationaha.124.071208

N/A

0.589DataRank · unranked

21 citations

J. Dawn Abbott, Brandon M. Herbert, Marnie Bertolet, Bernard Chaitman, Harvey D. White +19 more

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

American Heart Journal(2020)10.1016/j.ahj.2020.05.002

N/A

0DataRank · unranked

144 citations

Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Renata Moll‐Bernardes, André Feldman, Guilherme Arruda +10 more